Diapause-like adaptation of triple-negative breast cancer cells during chemotherapy treatment

三阴性乳腺癌细胞在化疗期间的滞育样适应

基本信息

  • 批准号:
    10616703
  • 负责人:
  • 金额:
    $ 19.13万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2022
  • 资助国家:
    美国
  • 起止时间:
    2022-05-02 至 2025-04-30
  • 项目状态:
    未结题

项目摘要

PROJECT SUMMARY Treatment with cytotoxic drugs often fail to completely eradicate breast cancers (BrCa) due to viable tumor cells that persist (“residual tumors”) and represent a reservoir for eventual relapse. In triple-negative breast cancer (TNBC), a highly lethal BrCa subtype, the presence of post-treatment residual cancer cells is strongly associated with aggressive disease relapse. Eradicating the drug-persistent TNBC foci could lead to cures, but their therapeutic vulnerabilities remain elusive, mainly because bona fide preclinical models of this cancer cell state amenable to genomic and pharmacological interrogation had been lacking. In our recent studies we demonstrated that treatment-persistent residual tumor cells adopt a distinct and reversible transcriptional program resembling that of embryonic diapause, a dormant stage of suspended development triggered by stress and associated with suppressed Myc activity and overall biosynthesis. Importantly, we developed 3-dimensional (3D) organoid based in vitro models (treatment-persistent organoids, TP-organoids) that faithfully recapitulate the phenotype and molecular profile of the residual tumors in PDX and in BrCa patients. To our knowledge, this is a first in vitro model of post-chemotherapy residual dormant cancer lesions. Our molecular and functional analyses strongly suggest that chemo-persistent dormant tumor cells possess distinct genomic and pharmacological vulnerabilities that are not reflected by historical cancer models (e.g. 2D cultures or conventional 3D/organoid cultures). The novelty and relevance of our models warrant the evaluation of putative mediators of the drug-persistent cancer cell state, which could reveal new, previously unappreciated, therapeutic targets for this clinically critical setting. In this exploratory project, we will combine our TNBC TP-organoid models of drug-persistent dormancy with genomic and pharmacological methods to i) identify the key mediators controlling TNBC cell exit from the dormancy state; and ii) develop therapeutic approaches that specifically kill dormant drug-persistent TNBC tumors. We will apply controllable loss-of-function (LOF) and gain-of-function (GOF) techniques to determine whether reactivation of Myc and/or other genes is necessary or sufficient for BrCa cells to exit dormancy. Similarly, we will use LOF approaches targeting genes commonly upregulated in our preclinical models of residual disease to assess their role on the viability of diapause-like persistent TNBC cells. In parallel, we will leverage the high-throughput capacity of our TP-organoid systems to map the landscape of pharmacological vulnerabilities of the chemo-persistent TNBC cells. The therapeutic value of candidate targets that enable the viability of persistent TNBC cells, or their exit from the dormant state, will be validated in appropriate in vivo residual disease models. This exploratory project will outline a first preclinical framework of therapeutic approaches to specifically target diapause-like drug-persistent TNBC tumors. Specifically targeting the candidate mediators that enable the viability during, or the exit from, treatment-induced protective dormancy of persistent residual cancer cells could lead to durable responses or even tumor eradication.
项目概要 由于肿瘤细胞存活,细胞毒性药物治疗通常无法完全根除乳腺癌 (BrCa) 持续存在的肿瘤(“残留肿瘤”)并代表最终复发的储存库。在三阴性乳腺癌中 (TNBC),一种高度致命的 BrCa 亚型,治疗后残留癌细胞的存在密切相关 患有侵袭性疾病复发。根除药物持久性 TNBC 病灶可能会带来治愈,但它们 治疗的弱点仍然难以捉摸,主要是因为这种癌细胞状态的真实临床前模型 缺乏接受基因组和药理学审讯的能力。在我们最近的研究中,我们 证明持续治疗的残留肿瘤细胞采用独特且可逆的转录 类似于胚胎滞育的程序,这是由压力引发的暂停发育的休眠阶段 并与 Myc 活性和整体生物合成受到抑制有关。重要的是,我们开发了 3 维 (3D) 基于类器官的体外模型(治疗持续性类器官,TP-类器官),忠实地再现 PDX 和 BrCa 患者中残留肿瘤的表型和分子特征。据我们所知,这 是第一个化疗后残留休眠癌症病灶的体外模型。我们的分子和功能 分析强烈表明,化疗持续休眠的肿瘤细胞具有独特的基因组和 历史癌症模型(例如 2D 培养物或 传统 3D/类器官培养)。我们模型的新颖性和相关性保证了对假定的评估 药物持续性癌细胞状态的介质,可能揭示新的、以前未被重视的治疗方法 这种临床关键环境的目标。在这个探索性项目中,我们将结合我们的 TNBC TP 类器官模型 使用基因组和药理学方法来研究药物持续休眠,以 i) 确定关键介质 控制TNBC细胞退出休眠状态; ii) 开发专门杀死病毒的治疗方法 休眠药物持续性 TNBC 肿瘤。我们将应用可控功能丧失(LOF)和功能获得 (GOF) 技术来确定 Myc 和/或其他基因的重新激活是否是必要或充分的 BrCa 细胞退出休眠。同样,我们将使用 LOF 方法来靶向通常上调的基因 我们的残留病临床前模型评估其对滞育样持续性 TNBC 生存能力的作用 细胞。与此同时,我们将利用 TP 类器官系统的高通量能力来绘制景观图 化疗持续性 TNBC 细胞的药理学脆弱性。候选靶点的治疗价值 使持久性 TNBC 细胞的生存能力或它们退出休眠状态的技术将在 适当的体内残留疾病模型。该探索性项目将概述第一个临床前框架 专门针对滞育样药物持续性 TNBC 肿瘤的治疗方法。针对性明确 候选介体能够在治疗引起的保护性休眠期间保持活力或从中退出 持续残留的癌细胞可能会导致持久的反应甚至肿瘤根除。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Eugen Dhimolea其他文献

Eugen Dhimolea的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Eugen Dhimolea', 18)}}的其他基金

Diapause-like adaptation of triple-negative breast cancer cells during chemotherapy treatment
三阴性乳腺癌细胞在化疗期间的滞育样适应
  • 批准号:
    10354304
  • 财政年份:
    2022
  • 资助金额:
    $ 19.13万
  • 项目类别:

相似海外基金

How novices write code: discovering best practices and how they can be adopted
新手如何编写代码:发现最佳实践以及如何采用它们
  • 批准号:
    2315783
  • 财政年份:
    2023
  • 资助金额:
    $ 19.13万
  • 项目类别:
    Standard Grant
One or Several Mothers: The Adopted Child as Critical and Clinical Subject
一位或多位母亲:收养的孩子作为关键和临床对象
  • 批准号:
    2719534
  • 财政年份:
    2022
  • 资助金额:
    $ 19.13万
  • 项目类别:
    Studentship
A comparative study of disabled children and their adopted maternal figures in French and English Romantic Literature
英法浪漫主义文学中残疾儿童及其收养母亲形象的比较研究
  • 批准号:
    2633211
  • 财政年份:
    2020
  • 资助金额:
    $ 19.13万
  • 项目类别:
    Studentship
A material investigation of the ceramic shards excavated from the Omuro Ninsei kiln site: Production techniques adopted by Nonomura Ninsei.
对大室仁清窑遗址出土的陶瓷碎片进行材质调查:野野村仁清采用的生产技术。
  • 批准号:
    20K01113
  • 财政年份:
    2020
  • 资助金额:
    $ 19.13万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
A comparative study of disabled children and their adopted maternal figures in French and English Romantic Literature
英法浪漫主义文学中残疾儿童及其收养母亲形象的比较研究
  • 批准号:
    2436895
  • 财政年份:
    2020
  • 资助金额:
    $ 19.13万
  • 项目类别:
    Studentship
A comparative study of disabled children and their adopted maternal figures in French and English Romantic Literature
英法浪漫主义文学中残疾儿童及其收养母亲形象的比较研究
  • 批准号:
    2633207
  • 财政年份:
    2020
  • 资助金额:
    $ 19.13万
  • 项目类别:
    Studentship
The limits of development: State structural policy, comparing systems adopted in two European mountain regions (1945-1989)
发展的限制:国家结构政策,比较欧洲两个山区采用的制度(1945-1989)
  • 批准号:
    426559561
  • 财政年份:
    2019
  • 资助金额:
    $ 19.13万
  • 项目类别:
    Research Grants
Securing a Sense of Safety for Adopted Children in Middle Childhood
确保被收养儿童的中期安全感
  • 批准号:
    2236701
  • 财政年份:
    2019
  • 资助金额:
    $ 19.13万
  • 项目类别:
    Studentship
A Study on Mutual Funds Adopted for Individual Defined Contribution Pension Plans
个人设定缴存养老金计划采用共同基金的研究
  • 批准号:
    19K01745
  • 财政年份:
    2019
  • 资助金额:
    $ 19.13万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Structural and functional analyses of a bacterial protein translocation domain that has adopted diverse pathogenic effector functions within host cells
对宿主细胞内采用多种致病效应功能的细菌蛋白易位结构域进行结构和功能分析
  • 批准号:
    415543446
  • 财政年份:
    2019
  • 资助金额:
    $ 19.13万
  • 项目类别:
    Research Fellowships
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了